Clinical Trials
78 trialsNCT07527832 2026-05-22
An Observational Study to Learn About the Medicine - BEVACIZUMAB BS [Pfizer] in Colorectal Cancer Patients From Japan.
Pfizer
Recruiting
NCT06117891 2026-05-12
REFINE-IO
Bayer
Active not recruiting
NCT04158258 2026-04-23
A Study to Describe the Diagnosis, Anti-Cancer Treatment and Clinical Outcome in Patients With Newly Diagnosed Breast Cancer in Latin America
Hoffmann-La Roche
Active not recruiting
NCT03451370 2026-04-15
COBRA
Istituto Oncologico Veneto IRCCS
Active not recruiting
NCT02394834 2026-04-13
An Exploratory Study of Treatment Sensitivity and Prognostic Factors in a Efficacy and Safety Study of mFOLFOX6 + Bevacizumab Versus mFOLFOX6 + Panitumumab Therapy in Patients With Chemotherapy-naïve Unresectable Advanced or Recurrent Colorectal Cancer
Takeda
Active not recruiting
NCT04862949 2025-12-12
Organ-specific Responses to Atezolizumab Plus Bevacizumab in Advanced HCC
CHA University
Completed
NCT05287464 2025-11-26
International Multicentric Study ARON-1
Hospital of Macerata
Recruiting
NCT05839951 2025-11-12
STAR-T
Bayer
Completed
NCT05197504 2025-09-05
HCC
CHA University
Completed
NCT02420509 2025-06-04
Postoperative Chemotherapy in High-Grade Appendiceal Adenocarcinoma With Peritoneal Carcinomatosis
University of California, San Diego
Terminated
NCT05525858 2025-04-27
KOSMOSII
Seoul National University Bundang Hospital
Recruiting
NCT05834348 2025-03-30
DELINOR
Pfizer
Completed
NCT05713994 2025-03-25
CCGLC-001
Tongji Hospital
Recruiting
NCT06858956 2025-03-05
Real-World Study of Chidamide Combined With PD-(L)1 Inhibitors and Anti-Angiogenic Therapy for Advanced MSS-Type Colorectal Cancer
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Not yet recruiting
NCT06849362 2025-02-27
Multicenter Retrospective Study on Optimizing Combination Immunotherapy Strategies in MSS/MSI-L/pMMR Advanced Colorectal Cancer
Central South University
Enrolling by invitation
NCT06827353 2025-02-14
OVNI-B
Centre Hospitalier Universitaire de Nīmes
Recruiting
NCT06682247 2024-11-12
A Real-world Study of Chidamide in Combination with PD-1/PD-L1 Antibodies and Anti-angiogenic Agents in Advanced MSS Colorectal Cancer
Sun Yat-sen University
Not yet recruiting
NCT05717738 2024-06-13
CCGLC-008
Tongji Hospital
Recruiting
NCT06447727 2024-06-07
Efficacy and Safety of 90Y Microsphere Combined With FOLFIRI and Bevacizumab in Second-line Treatment of CRLM
Zhongda Hospital
Recruiting
NCT05685836 2024-03-20
89Zr-Bevacizumab PET/CT Imaging in NF2 Patients
Leiden University Medical Center
Unknown
NCT05173298 2024-02-07
HCC
CHA University
Unknown
NCT06199297 2024-01-26
Atezolizumab Plus Bevacizumab Versus Sintilimab Plus Bevacizumab With TACE and HAIC in Unresectable Hepatocellular Carcinoma
Sun Yat-sen University
Completed
NCT03647592 2023-12-27
Real World Study on Erlotinib/Gefitinib Combined With Bevacizumab in Advanced Non-aquamous Non-small Cell Lung Cancer
Hunan Province Tumor Hospital
Unknown
NCT06031376 2023-09-11
Fruquintinib With PD-1 Inhibitors Versus TAS-102 With Bevacizumab in Late-Line mCRC
Hunan Cancer Hospital
Completed
NCT05354674 2023-07-13
Multimodal Deep Learning Signature for Evaluation of Response to Bevacizumab in Patient With Colorectal Cancer Liver Metastasis
Fudan University
Not yet recruiting
NCT05869097 2023-05-22
Trifluridine/Tipiracil Plus Bevacizumab Versus Trifluridine/Tipiracil Monotherapy in Refractory Metastatic Colorectal Cancer
Hunan Cancer Hospital
Completed
NCT04107168 2023-02-16
Microbiome Immunotherapy Toxicity and Response Evaluation
Cambridge University Hospitals NHS Foundation Trust
Unknown
NCT01745757 2023-01-27
COMET
UNICANCER
Completed
NCT02843230 2022-04-08
Monitoring Anti-angiogenic Therapy in Brain Tumors by Advanced MRI
Massachusetts General Hospital
Completed
NCT05177666 2022-01-04
a Prospective Registration Study for Patients With Advanced Refractory Solid Tumors
The University of Hong Kong-Shenzhen Hospital
Unknown
NCT01775644 2021-12-02
An Observational Study of Avastin in Participants With Metastatic Colorectal Cancer (KORALLE)
Hoffmann-La Roche
Completed
NCT04831528 2021-04-05
Decision-making of ctDNA in Patients With mCRC After Failure of First-line Treatment Containing Cetuximab - a Single-center, Phase II Clinical Study
Fudan University
Not yet recruiting
NCT04788381 2021-03-09
The Effects of Preoperative Bevacizumab on Perioperative Complications
Second Affiliated Hospital, School of Medicine, Zhejiang University
Unknown
NCT04575415 2020-10-20
BELLA
Guangdong Association of Clinical Trials
Unknown
NCT04213222 2020-08-11
ROBOT
Peking University People's Hospital
Unknown
NCT04397601 2020-05-21
ARBITRATION
National Cancer Institute, Naples
Unknown
NCT02613208 2020-02-17
Argo
Hoffmann-La Roche
Completed
NCT02745691 2019-12-13
Psychometric Properties of the EORTC QLQ-LC29
University Hospital Regensburg
Completed
NCT02393898 2019-07-24
BELOVA Data Collection: Safety and Efficacy of Frontline Bevacizumab Treatment in Participants With Ovarian Cancer 70 Years and Older
Hoffmann-La Roche
Completed
NCT03925233 2019-04-24
Breast Cancer Treatment Based on Organ-like Culture
Xijing Hospital
Unknown
NCT03923036 2019-04-22
AVOCETTE
University Hospital, Caen
Unknown
NCT03367182 2019-01-11
REBECA
Yonsei University
Completed
NCT02305615 2018-08-23
AVACONT
Hoffmann-La Roche
Completed
NCT01712347 2018-07-31
An Observational Study of First-Line Bevacizumab (Avastin) With Fluoropyrimidine-Based Chemotherapy in Participants With Metastatic Colorectal Cancer
Hoffmann-La Roche
Completed
NCT01506167 2018-05-14
An Observational Study of Avastin (Bevacizumab) in Patients With Metastatic Colorectal Cancer (ACORN)
Hoffmann-La Roche
Completed
NCT02093000 2018-02-23
A Study Examining Maintenance Bevacizumab (Avastin®) Monotherapy in Participants With Advanced Lung Adenocarcinoma
Hoffmann-La Roche
Completed
NCT02831842 2018-01-26
A Real World Study to Evaluate Effectiveness of Avastin (Bevacizumab) for First Line Treatment of Patients With Metastatic Colorectal Cancer and Known KRAS Status
Hoffmann-La Roche
Completed
NCT02623621 2017-12-07
CIRCUS
Azienda Ospedaliero, Universitaria Pisana
Completed
NCT03195569 2017-06-22
To Predict Efficacy by Detecting Circulating Endothelial Cell Subsets and Blood Perfusion Parameters Changes in Vivo Tumor in Study of QL1101 and Avastin® in Patients With Non-squamous Non-small Cell Lung Cancer
Qilu Pharmaceutical Co., Ltd.
Unknown
NCT03170284 2017-05-31
AVALANCHE
Hoffmann-La Roche
Completed